These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3775809)

  • 1. Genotoxicity of the pyrrolizidine alkaloid jacobine in rats.
    Petry TW; Bowden GT; Buhler DR; Sipes IG
    Toxicol Lett; 1986 Sep; 32(3):275-81. PubMed ID: 3775809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline.
    Petry TW; Bowden GT; Huxtable RJ; Sipes IG
    Cancer Res; 1984 Apr; 44(4):1505-9. PubMed ID: 6423276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of monocrotaline-induced hepatic genotoxicity in rats.
    Petry TW; Sipes IG
    Carcinogenesis; 1987 Mar; 8(3):415-9. PubMed ID: 3102099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of single-strand breaks and interstrand cross-links in liver DNA after the administration of 2-acetylaminofluorene and trans-4-acetylaminostilbene to rats.
    Ruthsatz M; Neumann HG
    J Biochem Toxicol; 1987; 2():271-9. PubMed ID: 3508479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides.
    Moore DJ; Batts KP; Zalkow LL; Fortune GT; Powis G
    Toxicol Appl Pharmacol; 1989 Nov; 101(2):271-84. PubMed ID: 2815083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity and cytotoxicity of selected pyrrolizidine alkaloids, a possible alkenal metabolite of the alkaloids, and related alkenals.
    Griffin DS; Segall HJ
    Toxicol Appl Pharmacol; 1986 Nov; 86(2):227-34. PubMed ID: 3787621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline.
    Yang X; Li W; Sun Y; Guo X; Huang W; Peng Y; Zheng J
    Chem Res Toxicol; 2017 Feb; 30(2):532-539. PubMed ID: 28095673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure-activity relationships.
    Hincks JR; Kim HY; Segall HJ; Molyneux RJ; Stermitz FR; Coulombe RA
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):90-8. PubMed ID: 1949039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxicity of the pyrrolizidine alkaloid monocrotaline following subchronic administration to C57Bl/6 mice.
    Deyo JA; Kerkvliet NI
    Fundam Appl Toxicol; 1990 May; 14(4):842-9. PubMed ID: 2113877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the induction of DNA single strand breaks in rats by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Wahba ZZ; Lawson TW; Murray WJ; Stohs SJ
    Toxicology; 1989 Sep; 58(1):57-69. PubMed ID: 2554534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat.
    Miranda CL; Cheeke PR; Buhler DR
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):573-87. PubMed ID: 6775360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hepatic DNA damage and methylene chloride-induced hepatocarcinogenicity in B6C3F1 mice.
    Graves RJ; Coutts C; Eyton-Jones H; Green T
    Carcinogenesis; 1994 May; 15(5):991-6. PubMed ID: 8200106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related inhibition of the drug-metabolizing enzymes of rat liver by the pyrrolizidine alkaloid, monocrotaline.
    Dalvi RR
    J Pharm Pharmacol; 1987 May; 39(5):386-8. PubMed ID: 2886588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antibacterial agents on in vitro ovine ruminal biotransformation of the hepatotoxic pyrrolizidine alkaloid jacobine.
    Wachenheim DE; Blythe LL; Craig AM
    Appl Environ Microbiol; 1992 Aug; 58(8):2559-64. PubMed ID: 1514802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxicity of a variety of pyrrolizidine alkaloids in the hepatocyte primary culture-DNA repair test using rat, mouse, and hamster hepatocytes.
    Mori H; Sugie S; Yoshimi N; Asada Y; Furuya T; Williams GM
    Cancer Res; 1985 Jul; 45(7):3125-9. PubMed ID: 4005849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
    Mathew R; Altura BT; Altura BM
    Magnesium; 1989; 8(2):110-6. PubMed ID: 2526910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
    Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
    Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
    Mattocks AR; Jukes R
    Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study.
    Ebmeyer J; Rasinger JD; Hengstler JG; Schaudien D; Creutzenberg O; Lampen A; Braeuning A; Hessel-Pras S
    Arch Toxicol; 2020 May; 94(5):1739-1751. PubMed ID: 32419051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.